CRISPR Therapeutics AG (CRSP) Increases Despite Market Slip: Here's What You Need to KnowZacks Investment Research • 06/18/25
CRISPR Therapeutics AG (CRSP) Goldman Sachs 46th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/09/25
CRISPR Therapeutics (CRSP) Up 11.1% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 06/05/25
CRISPR Therapeutics AG (CRSP) William Blair's 45th Annual Growth Stock Conference (Transcript)Seeking Alpha • 06/03/25
CRISPR Therapeutics Inks Collaboration Deal to Develop siRNA TherapiesZacks Investment Research • 05/20/25
CRISPR Therapeutics Stock Could Double Your Money, According to Wall Street. Is It Time to Buy?The Motley Fool • 05/20/25
Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?The Motley Fool • 05/12/25
Crispr Therapeutics: Complex Casgevy Launch, But Broader Gene-Editing Potential Still ShinesSeeking Alpha • 05/09/25
CRISPR Therapeutics Struggles Under Slow Adoption And Regulatory Uncertainty (Downgrade)Seeking Alpha • 05/08/25
CRISPR Therapeutics' Data Shows Promise, But RFK Jr. Appointee Could Be Negative: AnalystBenzinga • 05/07/25
CRISPR Therapeutics Q1 Earnings and Sales Miss Estimates, Stock TanksZacks Investment Research • 05/07/25
CRISPR Therapeutics AG (CRSP) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/06/25